Apr. 18, 2024
MONTPELLIER, FRANCE – Cilcare, a clinical-stage biotechnology company specializing in auditory sciences and developing novel therapies for inner ear and associated diseases, has expanded its partnerships with academic and public institutions in the United States and France. The University of Vermont Health Network and ARIS (Agence Régionale Investissements Stratégiques) have joined as new shareholders, alongside existing investors who have reaffirmed